NEW YORK, June 8, 2026 /PRNewswire/ -- The All Stars Project, Inc. (ASP) announced the launch of its new Artistic Advisory Council (Council), composed...
- Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action- Held in Namche Bazaar, Nepal, the...
Wendy's joins Illumination's Minions & Monsters with a custom menu lineup, exclusive collectibles and a drive-thru takeover in Los AngelesFresh Facts:Get ready to experience...
The merger brings FreeGame's full service athlete platform together with Prep's diamond sports expertise across representation, NIL, brand partnerships, and athlete education.CHARLOTTE, N.C., June...
GUANGZHOU, China, June 8, 2026 /PRNewswire/ -- Pony AI Inc. ("Pony.ai" or the "Company") (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale...
~ Godrej DEI Lab Launches Queer India Now!, a new anthology Under Queer Directions ~~ Introduces 'Queer India Fellowship' to Nurture Emerging Queer Leaders...
REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) lyophilized vial for intravenous administration.
HONG KONG, June 8, 2026 /PRNewswire/ -- The Fourth "Victoria Harbour Night Talk" concluded successfully on June 5 at Cloud 39, The Henderson, Central,...
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value...
HOOFDDORP, Netherlands, June 8, 2026 /PRNewswire/ -- EZVIZ, a world-leading smart home brand, announced to enter a new chapter of its EZVIZ Green Initiative by expanding...